If you are having trouble viewing this email, please view it on our website.

         
 
A PRODUCT
ANNOUNCEMENT
FROM:
  Pharmaceutical Executive  
 
 
     
 
 

 

Iroc Innocross AG, the innovators of corneal crosslinking, is delighted to announce the availablility of a new, unique system, UV-X2000.

Clinical Effectiveness;
Due to its unique beam profile, the UV-X2000 is the only available system that will achieve the same depth of crosslinking across the cornea, not just in the centre.
Speed;
UV illumination time reduced from 30 to 10 minutes.

Safety;
No greater effect on endothelial cells when the intensity is increased.

Loyalty;

All existing users can either upgrade or exchange their current systems to a new UV-X2000 on special terms.
Also, existing Iroc users can enter into a ballot to win a new I-Pad3.

Please send your contact details and serial number of your existing Iroc system to; [email protected]

For more information on UV-X2000, please select/click on link to www.irocmedical.com

Iroc,
Weidstrasse 24,
6300 Zug, Switzerland.
 

If you no longer wish to receive emails from Iroc Innocross, please reply to clickhere

Ophthalmology Times Europe is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ
This is an advertisement sent on behalf of this advertiser. 

http://www.technolaspv.com/ http://www.technolaspv.com/